KC-3354

CHOK1 mouse CD22 Middle Cell Line

×
Please enable JavaScript in your browser to complete this form.
26971
Home » CHOK1 mouse CD22 Middle Cell Line

Background of CHOK1 mouse CD22 Middle Cell Line

CD22 (CD22 Molecule) is a Protein Coding gene,This gene involved in several processes, including negative regulation of calcium-mediated signaling; negative regulation of immunoglobulin production; and regulation of B cell proliferation. It is integral component of plasma membrane.This gene is expressed in several structures, including alimentary system; brain; hemolymphoid system gland; liver and biliary system; and reproductive system. Diseases associated with CD22 include Refractory Hairy Cell Leukemia and Refractory Hematologic Cancer.

Specifications

Catalog NumberKC-3354
Cell Line NameCHOK1 mouse CD22 Middle Cell Line
Host Cell LineCHOK1
DescriptionStable CHOK1 cell line expressing exogenous mouse CD22 gene in middle level
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% RPMI1640 + 20% FBS + 10% DMSO
Propagation MediumRPMI1640 + 10% FBS + 10μg/ml Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:4-1:5 every 2-3 days; seed out at about 1-3 × 105 cells/ml
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 24 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

CHOK1 mouse-CD22-middle Cell Line was generated using a lentiviral vector expressing the mouse-CD22 sequence.

Characterization

Figure 1: Characterization of mouse-CD22 overexpression in the CHOK1 mouse-CD22 stable clone using FACS.

Cell Resuscitation

  1. Prewarm culture medium (RPMI1640 supplemented with 10% FBS and 10μg/mL Puromycin)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:5 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% RPMI1640 + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage

References

  1. Dörner T, Shock A, Smith KG. CD22 and autoimmune disease. Int Rev Immunol. 2012 Oct;31(5):363-78. doi: 10.3109/08830185.2012.709890. PMID: 23083346.
  2. Walker JA, Smith KG. CD22: an inhibitory enigma. Immunology. 2008 Mar;123(3):314-25. doi: 10.1111/j.1365-2567.2007.02752.x. Epub 2007 Dec 7. PMID: 18067554; PMCID: PMC2433339.
  3. Cesano A, Gayko U. CD22 as a target of passive immunotherapy. Semin Oncol. 2003 Apr;30(2):253-7. doi: 10.1053/sonc.2003.50057. PMID: 12720147.
Please enable JavaScript in your browser to complete this form.